12:00 AM
 | 
Jun 03, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Somatropin Biopartners regulatory update

EMA's CHMP recommended approval of once-weekly Somatropin Biopartners to treat growth hormone deficiency (GHD) in pediatric and adult patients. Somatropin Biopartners...

Read the full 84 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >